Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum Non Nocere

Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum Non Nocere

The prognosis of attention deficit hyperactivity disorder (ADHD) continues to “show heightened risk of multiple mental health and social difficulties as well as premature mortality in adult life” after nearly 50 years of primary pharmacological treatment.1 If the prognosis of ADHD is not changed by...

Full description

Bibliographic Details
Main Authors: Stern, Patrick H., Lipman, Jonathan, Anderson, Susan L., Bossaer, John B., Thigpen, Jim
Published: Digital Commons @ East Tennessee State University 2017
Subjects:
attention deficit hyperactivity disorder
mental health
ADHD
development
pharmacological treatment
brain
primum non nocere
Pharmacy Practice
Pharmacy and Pharmaceutical Sciences
Online Access:https://dc.etsu.edu/etsu-works/2329
https://doi.org/10.1177/0009922817706148

Similar Items

Similar Items